Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regenerx Biopharmaceuticals Inc (RGN)  
$0.01 0.00 (0.00%) as of 4:30 Tue 10/17


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 106,883,000
Market Cap: 1.04(M)
Last Volume: 9,926 Avg Vol: 77,919
52 Week Range: $0.009725 - $0.047
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   RegeneRX Biopharmaceuticals is a biopharmaceutical company focused on the development of a therapeutic peptide, Thymosin beta 4 (Tss4), for tissue and organ protection, repair, and regeneration. Co. has formulated Tss4 into three product candidates in clinical development: RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications that may be treated by systemic administration; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 140
  Page 4 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cavazza Paolo 10% Owner   –       –       •   2008-02-29 4 B $1.00 $2,500,000 I/I 2,500,000 4,555,985 1.5     -
   Cavazza Claudio 10% Owner   –       –       •   2008-02-29 4 B $1.00 $2,500,000 I/I 2,500,000 3,705,600 1.5     -
   Goldstein Allan L Director   –       •      –    2008-01-31 5 GD $0.00 $0 D/D 70,000 1,805,446     -
   Finkelstein J J President and CEO   •       •      –    2008-01-09 5 GD $0.00 $0 D/D 10,000 1,403,138     -
   Finkelstein J J President and CEO   •       •      –    2007-09-06 4/A B $1.56 $7,841 D/D 5,000 1,413,138 2.81     -
   Finkelstein J J President and CEO   •       •      –    2007-09-06 4 B $1.56 $7,841 D/D 5,000 1,433,138 2.81     -
   Lyons C Neil CFO and Treasurer   •       –      –    2007-08-29 4 A $1.96 $19,600 D/D 10,000 10,000     -
   Goldstein Allan L President and CEO   –       •      –    2007-08-28 5 GD $0.00 $0 D/D 5,000 1,875,446     -
   Finkelstein J J President and CEO   •       •      –    2007-07-20 5 GA $0.00 $0 I/I 10,000 38,500     -
   Finkelstein J J President and CEO   •       •      –    2007-07-20 5 GD $0.00 $0 D/D 20,000 1,413,138     -
   Mcnay Joseph C Director   –       •      –    2007-03-12 4 OE $0.10 $16,500 D/D 165,000 1,339,111     -
   Goldstein Allan L Director   –       •      –    2007-01-04 4 GD $0.00 $0 D/D 60,000 1,880,446     -
   Cavazza Paolo 10% Owner   –       –       •   2006-12-21 4 B $1.80 $2,999,999 I/I 1,666,666 2,055,985 1.5     -
   Defiante Farmaceutica Lda 10% Owner   –       –       •   2006-12-21 4 B $1.80 $1,499,999 I/I 833,333 12,011,185 1.5     -
   Cavazza Claudio 10% Owner   –       –       •   2006-12-21 4 B $1.80 $2,999,999 I/I 1,666,666 1,205,600 1.5     -
   Goldstein Allan L Director   –       •      –    2006-08-30 4 GD $0.00 $0 D/D 3,000 1,940,446     -
   Mcnay Joseph C Director   –       •      –    2006-07-17 4 OE $1.50 $39,474 D/D 26,316 1,174,111     -
   Defiante Farmaceutica Lda 10% Owner   –       –       •   2006-07-14 4 OE $1.50 $394,737 I/I 263,158 11,177,852     -
   Cavazza Paolo 10% Owner   –       –       •   2006-07-14 4 OE $1.50 $394,737 I/I 263,158 11,177,852     -
   Cavazza Claudio 10% Owner   –       –       •   2006-07-14 4 OE $1.50 $394,737 I/I 263,158 11,177,852     -
   Cavazza Paolo 10% Owner   –       –       •   2006-05-26 4 B $2.80 $350,000 I/I 125,000 1,222,652 1.5     -
   Finkelstein J J President and CEO   •       •      –    2006-05-26 4 S $2.80 $350,000 D/D (125,000) 1,428,138     -
   Goldstein Allan L Director   –       •      –    2006-05-03 4 GD $0.00 $0 D/D 9,090 1,943,446     -
   Cavazza Claudio 10% Owner   –       –       •   2006-03-06 4 B $2.81 $2,237,954 I/I 796,425 372,267 1.5     -
   Cavazza Paolo 10% Owner   –       –       •   2006-03-06 4 B $2.81 $2,237,954 I/I 796,425 10,914,694 1.5     -
  140 Records found
  1  2  3  4  5  6   
  Page 4 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us